Tebotelimab Antibody
Tebotelimab is a bispecific DART antibody that simultaneously targets PD-1 and LAG-3 immune checkpoints. It blocks inhibitory signaling to reverse T-cell exhaustion, thereby enhancing anti-tumor immunity, which supports its investigation in immuno-oncology research both in vitro and in vivo.
Product Specifications
Target
LAG-3
Clonality
Recombinant
Conjugation
Unconjugated
Field of Research
Immunology & Inflammation
Storage Conditions
Maintain refrigerated at 2-8°C for up to 2 weeks. For long term storage store at -20°C in small aliquots to prevent freeze-thaw cycles.
Notes
For research use only.
Available Sizes
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog
